Over the first half of the year, we've taken an in-depth look at guideline algorithms, best practice recommendations and expert advice on optimising outcomes in the earlier stages of type 2 diabetes. 

To help summarise all this guidance and put it into perspective, join Professor Peter Rossing of the Steno Diabetes Centre Copenhagen for a discussion of three model patient cases.

This independent educational activity is supported by an educational grant from Merck Sharp & Dohme Corp. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Merck Sharp & Dohme Corp has had no influence on the content of this education.